Sales & Marketing Disrupted medical conferences: Lessons learnt The new normal is already here. Get used to it.
Views & Analysis Are face-to-face medical meetings a thing of the past? Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception.
Views & Analysis What pharma can do to win in virtual Early data indications from the first virtual congresses shows big changes are needed.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.